21 results
8-K
EX-99.2
FNA
Paragon 28 Inc
8 May 24
Paragon 28 Reports First Quarter 2024 Financial Results
4:01pm
and younger patient populations Significant opportunity for innovation to drive improved outcomes Well over 100 indications with wide variety of causes
8-K
EX-99.1
FNA
Paragon 28 Inc
8 May 24
Paragon 28 Reports First Quarter 2024 Financial Results
4:01pm
on innovation and education across all foot and ankle segments has set us up well for continued sustainable growth.”
2024 Net Revenue Guidance
The Company
8-K
EX-99.1
FNA
Paragon 28 Inc
29 Feb 24
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
by committing to innovation and improving patient outcomes.”
2024 Net Revenue Guidance
The Company expects 2024 net revenue to be $249 million to $259
8-K
EX-99.2
nhd4kttfye dly
29 Feb 24
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
8-K
EX-99.2
pom n5g79
8 Jan 24
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
9:01am
8-K
EX-99.2
o56rslbzzttsop
7 Nov 23
Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
4:03pm
8-K
EX-99.1
h3o5fc
17 Mar 22
Regulation FD Disclosure
8:31am
10-K
r4g82vk3tgr24lx
8 Mar 22
Annual report
4:14pm
10-Q
xi9ji6cpm6b4ep
22 Nov 21
Quarterly report
8:16am
424B4
3r02peb79bh hov
18 Oct 21
Prospectus supplement with pricing info
4:34pm
S-1/A
022ux2h8n2u
29 Sep 21
IPO registration (amended)
5:17pm
S-1
65apxqrzti g04sjqpxq
24 Sep 21
IPO registration
5:07pm